Dr Pramod Pantangi, MBBS | |
1249 15th St Ste 3000, Huntington, WV 25701-3663 | |
(304) 691-1000 | |
Not Available |
Full Name | Dr Pramod Pantangi |
---|---|
Gender | Male |
Speciality | Gastroenterology |
Experience | 16 Years |
Location | 1249 15th St Ste 3000, Huntington, West Virginia |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1457667602 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RG0100X | Internal Medicine - Gastroenterology | 077752 (Georgia) | Secondary |
207RG0100X | Internal Medicine - Gastroenterology | 29610 (West Virginia) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Cabell Huntington Hospital Inc | Huntington, WV | Hospital |
St Mary's Medical Center | Huntington, WV | Hospital |
Pleasant Valley Hospital | Point pleasant, WV | Hospital |
Mon Health Medical Center | Morgantown, WV | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
University Physicians And Surgeons, Inc | 2961315734 | 324 |
Point Pleasant Physician Billing Services | 3375538184 | 29 |
Monongalia County General Hospital Company | 9638073380 | 182 |
News Archive
According to a new report from the Australian Institute of Health and Welfare, rural men are more prone to succumb to diseases like diabetes, some cancers like of head, neck and lip, poisonings and chronic health problems compared to those living in major cities.
For the estimated 10 percent of patients whose bodies reject a corneal transplant, the odds of a second transplant succeeding are poor. All that could change, however, based on a UT Southwestern Medical Center study that has found a way to boost the corneal transplant acceptance rate.
Treatment with the bisphosphonate zoledronate did not improve outcomes for women with chemoresistant breast cancer, according to initial results of a phase III clinical trial presented here at the 2013 San Antonio Breast Cancer Symposium, held Dec. 10-14.
An expert panel has created a new evidence-based guideline for managing sickle cell disease (SCD), with a strong recommendation for the use of the drug hydroxyurea and transfusion therapy for many individuals with SCD, although high-quality evidence is limited, with few randomized clinical trials conducted for this disease, according to an article in the September 10 issue of JAMA.
A drug that has been used for 40 years for the treatment of skin fungus has been found to be a possible cancer treatment, according to an international team of scientists. Leslie Wilson, professor of biochemistry and pharmacology at the University of California, Santa Barbara, said that the antifungal drug, griseofulvin, has been shown to inhibit the growth of cancer cells in his laboratory.
› Verified 6 days ago
Entity Name | University Physicians & Surgeons, Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1730183286 PECOS PAC ID: 2961315734 Enrollment ID: O20031107000331 |
News Archive
According to a new report from the Australian Institute of Health and Welfare, rural men are more prone to succumb to diseases like diabetes, some cancers like of head, neck and lip, poisonings and chronic health problems compared to those living in major cities.
For the estimated 10 percent of patients whose bodies reject a corneal transplant, the odds of a second transplant succeeding are poor. All that could change, however, based on a UT Southwestern Medical Center study that has found a way to boost the corneal transplant acceptance rate.
Treatment with the bisphosphonate zoledronate did not improve outcomes for women with chemoresistant breast cancer, according to initial results of a phase III clinical trial presented here at the 2013 San Antonio Breast Cancer Symposium, held Dec. 10-14.
An expert panel has created a new evidence-based guideline for managing sickle cell disease (SCD), with a strong recommendation for the use of the drug hydroxyurea and transfusion therapy for many individuals with SCD, although high-quality evidence is limited, with few randomized clinical trials conducted for this disease, according to an article in the September 10 issue of JAMA.
A drug that has been used for 40 years for the treatment of skin fungus has been found to be a possible cancer treatment, according to an international team of scientists. Leslie Wilson, professor of biochemistry and pharmacology at the University of California, Santa Barbara, said that the antifungal drug, griseofulvin, has been shown to inhibit the growth of cancer cells in his laboratory.
› Verified 6 days ago
Entity Name | Monongalia County General Hospital Company |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1447673223 PECOS PAC ID: 9638073380 Enrollment ID: O20031124000459 |
News Archive
According to a new report from the Australian Institute of Health and Welfare, rural men are more prone to succumb to diseases like diabetes, some cancers like of head, neck and lip, poisonings and chronic health problems compared to those living in major cities.
For the estimated 10 percent of patients whose bodies reject a corneal transplant, the odds of a second transplant succeeding are poor. All that could change, however, based on a UT Southwestern Medical Center study that has found a way to boost the corneal transplant acceptance rate.
Treatment with the bisphosphonate zoledronate did not improve outcomes for women with chemoresistant breast cancer, according to initial results of a phase III clinical trial presented here at the 2013 San Antonio Breast Cancer Symposium, held Dec. 10-14.
An expert panel has created a new evidence-based guideline for managing sickle cell disease (SCD), with a strong recommendation for the use of the drug hydroxyurea and transfusion therapy for many individuals with SCD, although high-quality evidence is limited, with few randomized clinical trials conducted for this disease, according to an article in the September 10 issue of JAMA.
A drug that has been used for 40 years for the treatment of skin fungus has been found to be a possible cancer treatment, according to an international team of scientists. Leslie Wilson, professor of biochemistry and pharmacology at the University of California, Santa Barbara, said that the antifungal drug, griseofulvin, has been shown to inhibit the growth of cancer cells in his laboratory.
› Verified 6 days ago
Entity Name | Point Pleasant Physician Billing Services |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1396798898 PECOS PAC ID: 3375538184 Enrollment ID: O20040419001780 |
News Archive
According to a new report from the Australian Institute of Health and Welfare, rural men are more prone to succumb to diseases like diabetes, some cancers like of head, neck and lip, poisonings and chronic health problems compared to those living in major cities.
For the estimated 10 percent of patients whose bodies reject a corneal transplant, the odds of a second transplant succeeding are poor. All that could change, however, based on a UT Southwestern Medical Center study that has found a way to boost the corneal transplant acceptance rate.
Treatment with the bisphosphonate zoledronate did not improve outcomes for women with chemoresistant breast cancer, according to initial results of a phase III clinical trial presented here at the 2013 San Antonio Breast Cancer Symposium, held Dec. 10-14.
An expert panel has created a new evidence-based guideline for managing sickle cell disease (SCD), with a strong recommendation for the use of the drug hydroxyurea and transfusion therapy for many individuals with SCD, although high-quality evidence is limited, with few randomized clinical trials conducted for this disease, according to an article in the September 10 issue of JAMA.
A drug that has been used for 40 years for the treatment of skin fungus has been found to be a possible cancer treatment, according to an international team of scientists. Leslie Wilson, professor of biochemistry and pharmacology at the University of California, Santa Barbara, said that the antifungal drug, griseofulvin, has been shown to inhibit the growth of cancer cells in his laboratory.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Pramod Pantangi, MBBS 60 Presidential Plz Apt 1005, Syracuse, NY 13202-2218 Ph: (315) 484-8994 | Dr Pramod Pantangi, MBBS 1249 15th St Ste 3000, Huntington, WV 25701-3663 Ph: (304) 691-1000 |
News Archive
According to a new report from the Australian Institute of Health and Welfare, rural men are more prone to succumb to diseases like diabetes, some cancers like of head, neck and lip, poisonings and chronic health problems compared to those living in major cities.
For the estimated 10 percent of patients whose bodies reject a corneal transplant, the odds of a second transplant succeeding are poor. All that could change, however, based on a UT Southwestern Medical Center study that has found a way to boost the corneal transplant acceptance rate.
Treatment with the bisphosphonate zoledronate did not improve outcomes for women with chemoresistant breast cancer, according to initial results of a phase III clinical trial presented here at the 2013 San Antonio Breast Cancer Symposium, held Dec. 10-14.
An expert panel has created a new evidence-based guideline for managing sickle cell disease (SCD), with a strong recommendation for the use of the drug hydroxyurea and transfusion therapy for many individuals with SCD, although high-quality evidence is limited, with few randomized clinical trials conducted for this disease, according to an article in the September 10 issue of JAMA.
A drug that has been used for 40 years for the treatment of skin fungus has been found to be a possible cancer treatment, according to an international team of scientists. Leslie Wilson, professor of biochemistry and pharmacology at the University of California, Santa Barbara, said that the antifungal drug, griseofulvin, has been shown to inhibit the growth of cancer cells in his laboratory.
› Verified 6 days ago
Leonard White, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1249 15th St, Suite 2000, Huntington, WV 25701 Phone: 304-691-1000 Fax: 304-691-1153 | |
George J Linsenmeyer Iii, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1249 15th St Ste 4000, Huntington, WV 25701 Phone: 304-691-8500 | |
Maria Gracia Luzuriaga Bassante, MD Gastroenterology Medicare: Medicare Enrolled Practice Location: 1249 15th St Ste 3000, Huntington, WV 25701 Phone: 304-691-1000 | |
Dr. Everett B Wray Iii, M.D. Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 1249 15th Street, Suite 4000, Huntington, WV 25701 Phone: 304-691-8500 Fax: 304-691-8510 | |
Mustafa Awili, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2900 First Avenue, Room 1025, Huntington, WV 25702 Phone: 304-399-7484 Fax: 304-399-7579 | |
Helgi K Sigmundsson, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 5170 Us Rt 60 East, Huntington, WV 25705 Phone: 304-528-4600 | |
Sara Catherine Allman, MD Gastroenterology Medicare: Medicare Enrolled Practice Location: 1540 Spring Valley Dr, Huntington, WV 25704 Phone: 304-429-6741 Fax: 304-429-0362 |